Maravai shares rise 11.04% intraday after Q4 results beat expectations, EBITDA turns positive, and early restructuring saves $65M.

Maravai surged 11.04% intraday trading, driven by stronger-than-expected Q4 financial results including $49.87 million revenue (vs. $49.05 million estimate) and a positive adjusted EBITDA of $536,000 (vs. -$4.02 million estimate), alongside a 2026 sales guidance of $205 million exceeding forecasts and early restructuring progress with $65 million annual cost savings (vs. $50 million target) and $50 million debt repayment.